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Abstract
The indolamine melatonin (MEL) is described as an antioxidant and a free radical scavenger. However occasionally, the
indoleamine has been reported to increase free radicals with insufficient mechanistic explanation. In an attempt to find a
reason for those controversial results, a potential mechanism that explains MEL prooxidant activity is investigated. The
current controversy about redox detection methods has prompted us to search a possible interaction between MEL and
dichlorodihydrofluorescein (DCFH2), perhaps the most widely fluorescence probe employed for free radicals detection in
cellular models. Here, it is demonstrated that melatonin potentiates the photooxidation of DCFH2 in a cell-free system,
increasing the production of its fluorescent metabolite. Indeed, MEL works as an antioxidant scavenging hydroxyl radicals in
this system. Thus, this reaction between MEL and DCFH2 produces N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK), a
biogenic amine with antioxidant properties too. This reaction is O2 and light dependent and it is prevented by antioxidants
such as N-acetylcysteine or ascorbic acid. Furthermore, when DCFH2 has been employed to evaluate antioxidant or
prooxidant activities of MEL in cellular models it is confirmed that it works as an antioxidant but these results can be
modulated by light misleading to a prooxidant conclusion. In conclusion, here is demonstrated that DCFH2, light and
melatonin interact and results obtained using these fluorescence probes in studies with melatonin have to be carefully
interpreted.
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Introduction
Oxidative stress has an important impact in human health. Its
implication in several disorders including atherosclerosis, diabetes,
neurodegeneration or cancer has been widely investigated. The
principal components of oxidative stress are a variety of chemical
species such as nitric oxide (NO), superoxide anions (O2
N2),
hydroxyl radicals (NOH) and hydrogen peroxide (H2O2) among
others. Some of these molecules are generated exogenously or
produced endogenously from several sources including oxidative
phosphorylation in mitochondria. Given its important role in
physiology and pathology, there is an increasing interest in
developing accurate methods to measure free radical production in
cells.
One of the principal drawbacks of oxidative stress research has
been the accuracy when measuring ROS production in in vivo
systems. There are currently several methods developed for
measuring free radicals inside cells including chemiluminescence
of luminol or lucigenin [1], cytochrome c reduction [2] or ferrous
oxidation of xylenol orange [3] as well as some other commercially
available fluorescence probes. However, among all of them, 29,79-
dichlorofluorescein (DCF) staining is by far the most widely
employed for the analysis of ROS and cellular oxidative stress
[4,5]. To measure ROS in cells [6], DCFH2-DA is used because it
can be easily taken up and it is more resistant to oxidation than
DCFH2. Upon internalization it is rapidly de-acetylated and after
that it reacts with ROS to produce a fluorescence product [7].
Given its simplicity and sensitivity, DCFH2-DA [4] has been
employed to study the production of H2O2 [8] in several reports
by using microplate reader [9] or flow cytometry methods [10].
N-acetyl-5-methoxy-tryptamine or melatonin is an indolamine
produced endogenously and secreted into circulation mainly by
pineal gland though it is also synthesized in many other locations.
In all species studied thus far, its synthesis from tryptophan occurs
during darkness [11,12]. Considering its nocturnal synthesis,
melatonin has been linked to sleep promotion [13], a chemical
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signal of light:dark cycle [14], and a regulator of reproductive
physiology in seasonal breeding mammals among others [15].
Besides regulating circadian and circannual rhythms, melatonin is
a major endogenous antioxidant and a free radical scavenger [16].
Melatonin functions as a direct-scavenging molecule and it also
stimulates indirectly gene expression and activities of antioxidant
enzymes [17]. As a direct scavenger, melatonin reacts with
different free radicals including NOH, O2
N2, NON and alkyl-peroxyl
radicals [18–20] and indirectly, it stimulates glutathione produc-
tion and the activities of both, glutathione peroxidase and
superoxide dismutase [21,22]. There is an inverse relationship
between melatonin levels and tumour growth, in terms of initiation
but also, of progression and metastasis [23]. Although numerous
mechanisms have been identified to explain melatonin inhibition
of cancer [24], its role as an intracellular redox regulator has been
well documented as one of the mechanism by which it could
modulate cancer growth [25]. Melatonin has been mostly reported
to inhibit cell growth by reducing free radicals production or
activity [26] but also, it has been suggested that melatonin by itself
promotes cell toxicity and death of some tumour cells through a
prooxidant pathway [27–30].
Antioxidant and prooxidant activities of melatonin have been
previously evaluated by using DCFH2 or DCFH2-DA staining by
other researchers. Furthermore, there are several cases of
interactions between DCFH2 or DCFH2-DA with other mole-
cules. So, a set of experiments to assess any potential interaction
between melatonin with DCFH2 or DCFH2-DA are performed to
clarify discrepancies observed about antioxidant or prooxidant




29-79-dichlorodihydrofluorescein diacetate (DCFH2-DA) was
purchased from Invitrogen (Life Technologies, Alcobendas,
Madrid, Spain). All other chemicals were purchased from
Sigma-Aldrich (Tres Cantos, Madrid, Spain). Melatonin (Merck,
Darmstadt, Germany) stock (1 M) was prepared in DMSO and
then diluted until desired concentration directly in phosphate
buffer saline (PBS). Other reagents including catalase (CAT),
superoxide dismutase (SOD), ascorbic acid (AA), N-acetyl cysteine
(NAC) or H2O2 were freshly prepared in PBS and used
immediately for all assays.
Light-dark experiments
Light-dark experiments were performed in a hermetic box
protected from external light and equipped with a light bulb
located at 15 cm from samples. Light used was a 6W linear
fluorescent (F6T5/D, GE lighting # 10028) with the following
features: Initial Lumen (NOM) 230, Median Lumen (NOM) 185,
Colour temperature 6500 K, Nominal initial lumen per Watt
(NOM) 38. Other specific parameters such as spectral, power
distribution or electric characteristic can be checked at the
company web site (www.gelighting.com). Light power reaching
samples was 25000 lux. All the experiments were performed at
RT. All solutions were placed in open tubes and at the same time
for each experiment. Dark experiments were carried out in the
same conditions than light experiments but in this case light of box
was turned off.
DCFH2 preparation
For cell-free experiments DCFH2-DA was deacetilated to
DCFH2 prior to each experiment following the method described
before [31]. Briefly, 0.5 ml DCFH2-DA (1.0 mM in methanol) was
mixed with 2 ml of NaOH (0.01 M) for 30 minutes at RT. Then,
mixture was neutralized by adding 10 ml of NaH2PO4 (25 mM,
pH 7.4). Final solution 1 mM DCFH2 was employed within
15 minutes after dilution.
Fluorescence and absorbance spectroscopy
Absorption spectra of samples containing DCFH2-DA or
DCFH2 in PBS at pH 7.4 with or without MEL, H2O2, AA,
SOD or CAT were measured by using a Cary 50 Bio UV-Vis
spectrophotometer (Agilent Technologies, Santa Clara, CA, USA)
at room temperature. Changes in absorption were quantified at
501 nm (lmax of DCF).
Fluorescence were measured in quartz cuvettes using a Cary
Eclipse fluorimeter (Agilent Technologies, Santa Clara, CA USA)
at RT (lexc = 480 nm, lem = 500–700 nm). Voltage was set
between 400 and 800 V. Since voltage was changed to get
enough acquisition, all groups from the same set of experiments
were measured at the same time, using the same voltage intensity.
For studies under a N2 atmosphere, an atmosbag glove bag
(Sigma-Aldrich) was used.
HPLC measurements
HPLC analysis was performed on 1260 Infinity HPLC system
(Agilent Technologies, USA) equipped with a binary pump with
solvent selection valves, online degasser and a programmable auto-
sampler. A tracer Extrasil ODS1 column (250 mm60.46 mm,
5 mm) (Teknokroma, Barcelona, Spain), operating at 35uC was
used. An ODS guard column was placed previously to protect the
analytical column. Mobile phase solution was always filtered
through a 0.45 mm membrane filter. Identification of the
compounds was determined by their retention time (RT) and
UV spectrum. All measurements were performed using Chemsta-
tion software.
HPLC analysis of MEL, N1-acetyl-N2-formyl-5-methoxykynur-
amine (AFMK), N1-acetyl-5-methoxykynuramine (AMK) or cyclic
3-hydroxymelatonin (3-COHM) was performed as previously
described [32]. Briefly, sodium acetate (20 mM, pH 5.1) in 35%
methanol was used as mobile phase. A flow of 0.9 ml/min and
different wavelengths (190 at 800 nm) were employed to obtain
the spectrum of absorbance for each compound. The elution order
was 3-COHM, AMK, MEL and AFMK and absorbance was set
at 230/279 nm (absolute/relative maximum) for MEL, 233/
380 nm for AMK, 233/337 nm for AFMK and 231/306 for
3COHM. Quantification was performed at 231 nm. Standards of
AFMK, AMK and 3COHM were synthesized by using the
method reported by Tan et al [33]. Thus, H2O2 was diluted to
50 mM with PBS (50 mM, pH 7.0) and deferoxamine was
dissolved in this solution at a final concentration of 1 mM to
chelate any possible trace of free iron. MEL was then added to this
solution to make a final concentration of 1 mM. The mixture was
incubated for 2 h at RT. The majority components of this solution
were then mixed with an equal volume of dichloromethane and
shaken horizontally for 10 min. The water phase was discarded
and the organic phase was dried under vacuum. The residue was
dissolved in a small volume of methanol and fractionated by
analytical thin layer chromatography with silica gel on polyester,
fluorescent indicator, layer of 250 mm and 20 3 20 cm (TLC)
using ethyl acetate as the solvent. The major spot (about 90% in all
metabolites), which migrated with an RF of 0.2 (detected with UV
lamp at 254 nm) was scraped from the TLC plate and extracted
with methanol. The TLC purification was repeated two additional
times. The purified product was identified to be AFMK by simple
1H-NMR. For AMK synthesis, the above purified AFMK was
Melatonin and DCF Interaction
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dissolved in PBS buffer (50 mM, pH 7.0) at a final concentration
of 7 mM and incubated with catalase (2500 U/ml) at room
temperature for 24 h. The solution was mixed with two portions of
dichloromethane (per volume) and shaken horizontally for 10 min.
The water phase was discarded and the organic phase was dried
under vacuum. The residue was then dissolved in a small volume
of methanol and the enzyme metabolite was fractionated by
analytical TLC using ethyl acetate as the solvent. The single
metabolite produced by catalase was isolated from TLC plate as
described above and identified to be the AMK by 1H-NMR.
DCFH2 and DCF were separated by HPLC in an isocratic
mode following the method previously reported [34]. A mixture of
NaH2PO4 (20 mM, pH 6.8) and methanol (43:57) was used as
mobile phase. Flow was set at 1 ml/min, at RT and 20 ml of
sample were injected. Wavelengths between 190 and 800 nm were
used.
HPLC-MS was used to confirm presence of AFMK in samples.
Agilent 1290 Infinity (HPLC) and Agilent 6460 triple quad (MS)
equipped with a Zorbax Eclipse Plus C18 column (Agilent,
2.1650 mm, 1.8 mm particle) were used. Mobile phase consisting
in two components (A 0.1% formic acid; B ACN with 0.1% formic
acid) in gradient mode (5% B to 90% B, 1 to 6 min) with a flow of
250 ml/min at 30uC and 2 ml of injection volume were the optimal
parameters chosen. Flow of 5 L/min and temperature of 300uC of
nebulization gas was chosen. ESI positive at 3500 V, product ion
mode (m/z ion 265 (M+H)+) and 10 eV as Collision Energy to
fragment precursor ion was used.
Cell culture experiments
Hippocampal neuronal (HT22) and prostate cancer (PC3) cell
lines were cultured in DMEM and DMEM/F12 respectively,
supplemented with 10% FBS and 1% antibiotic-antimycotic
cocktail. Cells were grown at 37uC in a humidified 5% CO2
environment, seeded at a density of 25,000 cell/mL of complete
media in 6 or 96 well plates and allowed to attach overnight before
experiments. Cells were incubated 24 hours with or without
1 mM MEL. Thereafter, medium was replaced and KRH buffer
(50 mM HEPES, 137 mM NaCl, 4.7 mM KCl, 1.85 mM CaCl2,
1.3 mM MgSO4, 0.1% BSA, pH: 7.4) with 10 mM of 2,7-
dichlorofluorescein diacetate (DCFH-DA) was added for 30 min
at 37uC in darkness. Fluorescence was measured after 30 min in a
microplate reader (lex 485 nm, lem 530 nm - mQuant, Biotek) or
from flow cytometer (Beckman-Coulter EPICS-XL Cytometer) as
previously described [9,35].
Results
Evaluation of DCFH2-DA photooxidation in the presence
of melatonin
DCFH2-DA is one of the most widely employed fluorescence
probe to measure redox state inside cells. It is a cell permeable
precursor of DCFH2 that can readily cross membrane. After
internalization, it is cleaved by intracellular esterases giving
DCFH-DA obtaining DCFH2. Therefore, to evaluate a possible
interference in the fluorescence of DCF caused by MEL and light
reaction, both molecules (DCFH2 and DCFH2-DA) were
employed. Thus, DCFH2-DA photooxidation was evaluated by
Figure 1. Effect of melatonin on light-induced DCFH2-DA oxidation. A) Fluorescence spectrum (lexc = 485 nm, lem = 500–700 nm) of DCFH2-
DA (100 mM) plus MEL (1 mM) under light (0–40 min). B) Fluorescence of several concentrations of DCFH2-DA plus MEL (1 mM) and light 60 minutes.
***p,0.001 vs no treat. C) Fluorescence of DCFH2-DA plus MEL (1 mM) during 5, 20 or 40 minutes under light or dark conditions. ***p,0.001 vs
Darkness. D) Absorbance Spectrum (350–700 nm) of DCFH2-DA (100 mM) or MEL (1 mM) alone or mixed under 30 minutes of dark or light conditions.
E) Absorbance measurement at 505 nm of MEL (1 mM), DCFH2-DA (100 mM), alone or mixed under 30 minutes of light or dark conditions. ***p,
0.001 vs Darkness.
doi:10.1371/journal.pone.0109257.g001
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measuring fluorescence emission of its oxidant product in the
presence or absence of MEL in both, under light or in darkness.
When DCFH2-DA was mixed with MEL and exposed to light at
different times, a significant increase in fluorescence emission was
observed (Fig. 1A). This increase of fluorescence was clearly
dependent on time, DCFH2-DA concentration (Fig. 1B) and light
(Fig. 1C). Similarly, when DCFH2-DA alone or plus MEL were
exposed to light/dark and absorbance was measured, MEL
increased significantly the absorbance of DCFH2-DA (Fig. 1D, E).
Evaluation of DCFH2 photooxidation in the presence of
melatonin
Once it was observed the enhancement of DCFH2-DA
photooxidation by MEL, the interaction of DCFH2 and MEL
was also studied. DCFH2-DA was deacetylated to DCFH2 which
was then mixed with MEL under light. As reported above, a
significant increase of time-dependent fluorescence when 100 mM
DCFH2 was exposed to light was observed. By using 10 mM
DCFH2 plus 1 mM MEL under light, fluorescence was rapidly
increased after few seconds (Fig. 2A). Chromatogram presented in
figure 2B showed a production of DCF compound after 60, 120,
240 and 300 seconds plus light and MEL. As shown, after only
60 seconds of exposition to MEL and light, DCF peak is 10 times
higher than control.
Evaluation of DCFH2 and DCFH2-DA photooxidation in
the presence of melatonin under UV light or in a N2
atmosphere
In addition to visible light, UV light was employed to evaluate
the photooxidation of DCFH2 and DCFH2-DA. After DCFH2
exposure to UV light, there was an increase in fluorescence, and
again, that increase was dependent on time. Similarly to what
happens under visible light, when DCFH2 was incubated with
MEL under UV light, fluorescence emission was significantly
higher (Fig. 3A). The increment of fluorescence under UV light is
much higher than under visible light since even lower compound
concentration gives a much faster time of reaction. The spectrum
of fluorescence after light exposure at different times is shown in
supplementary material. The increment of fluorescence is 10 times
higher when DCFH2 was combined with MEL under UV light
than when DCFH2-DA was employed (Figure S1A). Likewise,
MEL was able to increase by 100 fold the fluorescence of DCFH2
when they were exposed to UV light for several minutes (Figure
S1B).
Figure 2. Time-dependence in melatonin effect on DCFH2 photooxidation. A) Time course of DCF production by DCFH2 (10 mM) alone (-#-)
or plus MEL 1 mM (-N-) under light. B) Chromatogram of DCF after DCFH2 (10 mM) plus MEL (1 mM) were exposed to light for 60, 120, 240 or
300 seconds.
doi:10.1371/journal.pone.0109257.g002
Figure 3. Role of UV light and O2 in DCFH2-DA and DCFH2 photooxidation. A) Fluorescence of DCFH2 (10 mM) or DCFH2-DA (100 mM) plus
MEL (1 mM) under UV light. B) Fluorescence of DCFH2 (10 mM) plus MEL (1 mM) under N2 or normal atmosphere.
doi:10.1371/journal.pone.0109257.g003
Melatonin and DCF Interaction
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To check if atmospheric O2 has an important role in
photooxidation of DCFH2 by MEL, an experiment under N2
was performed. When O2 was eliminated from solution fluores-
cence did not increase. After 2 minutes under light, fluorescence
intensity under N2 atmosphere is clearly lower than under normal
atmosphere (Fig. 3B). For these experiment it is possible to
conclude that O2 plays an instrumental role in the photooxidation
process.
Participation of H2O2 generation by melatonin in DCFH2
or DCFH2-DA photooxidation
In order to understand the mechanism of DCFH2 photooxida-
tion by MEL, H2O2 was included in the DCFH2 plus MEL
mixture solution. After 300 seconds under visible light, the
increment of fluorescence was measured. As previously described
by others [7], an increment of DCF was observed after either
H2O2 or MEL addition (Fig. 4A). In previous reports [7,36,37],
the activity of antioxidant enzymes in preventing DCF formation
was studied to demonstrate its dependence on ROS production.
Consequently, catalase (CAT), superoxide dismutase (SOD), N-
acetyl-cysteine (NAC) or ascorbic acid (AA) were employed to
inhibit DCF formation after DCFH2 or DCFH2-DA plus MEL
under light. CAT or SOD did not inhibit DCF formation after
DCFH2 plus MEL exposure under light but they clearly reduced
its formation after DCFH2 exposure alone (Fig. 4B). On the
contrary, antioxidants such as AA or NAC inhibited DCF
fluorescence when both DCFH2 (Fig. 4B) or DCFH2-DA (Fig. 4C)
were incubated alone or plus MEL under light [38,39].
Production of kynureamines after DCFH2 and melatonin
reaction
Previous studies focused on photooxidation of MEL by
protoporphyrin IX [40] or by 2-hydroxyquinoxaline [41] showed
the presence of several kynureamines as metabolites. For this
reason, N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK), N1-
acetyl-5-methoxykynuramine (AMK) or cyclic 3-hydroxymelato-
nin (3-COHM) were studied after DCFH2 exposure to light in the
presence of MEL. When DCFH2 plus MEL was exposed for
Figure 4. Impact of antioxidants on melatonin enhancement of DCFH2 and DCFH2-DA photooxidation. A) Fluorescence of DCFH2
(10 mM), MEL (1 mM), H2O2 (10 mM) alone or in combination under light for 300 second. B) Evaluation of fluorescence of DCFH2 (10 mM) with CAT
(200 U), SOD (200 U), NAC (10 mM) and AA (10 mM) with or without supplementation of MEL (1 mM) under light for 300 seconds. C) Evaluation of
fluorescence of DCFH2-DA (100 mM) with CAT (200 U), SOD (200 U), NAC (10 mM) and AA (10 mM) with or without supplementation of MEL (1 mM)
under 30 min seconds of light exposure.
doi:10.1371/journal.pone.0109257.g004
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30 seconds under light, we found a significant reduction of MEL
concomitant with the presence of some new products. By
comparing retention time as well as uv-spectrum with AFMK,
AMK or 3-COHM standards, it was confirmed that AFMK was
found after DCFH2 plus MEL were exposed to light (Fig. 5A). To
ensure that AFMK is the compound generated in this reaction, a
molecules produced and AFMK standard were compared by
HPLC-MS obtained a positive confirmation of AFMK generation
(Fig. 5B). The formation of AFMK requires the presence of two
oxygen atom. Thus, when these experiments were performed in
pure DMSO, DCF fluorescence was not found (data not shown).
Dose response study of DCFH2 photooxidation by
melatonin
A dose response study was made by using 0.1 mM of DCFH2
and 3 mM MEL, the concentration of the indole found inside
prostate LNCaP cells when they are incubated with 1 mM MEL
for 6 hours [42]. Under these conditions, an increase of
fluorescence was observed even after only 30 seconds (Fig. 6A).
In addition, by using AA as antioxidant, there was a clear
reduction in DCF formation also in a dose dependent manner
(Fig. 6B). Furthermore a higher dose response study was done. So,
Figure 5. Presence of melatonin metabolites in DCFH2 photooxidation enhanced by melatonin. A) Chromatogram of standards of 3-
COHM, AMK, AFMK and MEL (blue line), chromatogram of MEL (1 mM) with DCFH (10 mM) under light 5 min (red) or 10 min (green). B)
Chromatogram and mass-spectrum obtained by HPLC-MS of AFMK standard (black) and AFMK present in sample (red) after MEL (1 mM) incubation
with DCFH (10 mM) after 5 min of exposure to light.
doi:10.1371/journal.pone.0109257.g005
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in all MEL concentrations studied 21 nM to 1 mM- an increase
in fluorescence was observed (Figure S2).
DCFH2 photooxidation by MEL in culture cells
Prostate cancer (PC3) and hippocampal neuronal (HT22) cells
were incubated with or without 1 mM MEL for 24 hours. Then,
10 mM of DCFH2-DA was added for 30 min prior to cytometer or
fluorometric measurement. Those experimental conditions were
chosen because there were normally employed by investigations
describing pro-oxidant activity of the indoleamine [27,43–45].
Changes in fluorescence among experimental groups were
detected in both cell lines. Thus, when cells are incubated with
MEL, a decrease in fluorescence is observed only when all
experiment is performed in complete darkness (Fig. 6 C,D). When
HT22 cells were exposed to light only for 1 minute, an increase of
fluorescence and therefore DCF formation was observed. Same
results were found in PC3 cells but light effect was lower. Thus,
after 2 min under light an increase in fluorescence was also
observed.
According to our results, a hypothetical pathway describing the
potential reactions between DCFH2 and MEL are shown in
Figure 7.
Discussion
This study tried to understand an apparent dual role of MEL as
pro-oxidant or anti-oxidant molecule. Mostly, the indolamine has
been considered to scavenges free radicals or stimulates cell
antioxidant defense [11,17] while some reports described a pro-
oxidant activity that in some context might induce cell death
[27,28]. The number of references that describe MEL as a pro-
oxidant factor are considerably fewer that those describing
antioxidant properties of the indole and also, few mechanistic
explanations are proposed to explain its activity in promoting free
radicals.
Figure 6. Dose dependence of DCFH2 in melatonin enhancement of photooxidation in vitro and in cellular models. A) Fluorescence of
DCFH2 (0.1 mM) alone or plus MEL (3 mM) under light. B) Fluorescence of DCFH2 (0.1 mM) alone plus MEL (3 mM) or MEL (1 mM) in combination with
AA (1–1000 mM) under light exposure for 60 seconds. C) Fluorescence, detected by flow cytometer, of HT22 cells incubated with 10 mM DCFH2 alone
(1) or with 1 mM MEL plus 10 mM DCFH2 in darkness (2) or after 2 minutes of light exposure (3). D) Fluorescence, detected by microplate fluorimeter,
of PC3 cells incubated with DCFH2 (10 mM) alone or with 1 mM MEL plus DCFH2 (10 mM) in darkness or after 1, 2 and 3 minutes of light exposure.
doi:10.1371/journal.pone.0109257.g006
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There is a clear controversy about the challenges and limitations
of assay methods for measuring ROS [46]. In fact, some
investigators considered essential to keep this limitations in mind
for proper interpretation of data obtained [47]. Several reports
have showed that DCFH2 is even oxidized in processes that do not
actually involve ROS. Also, photo-irradiation incidental to
spectrofluorometric or fluorescence microscopy observation has
also been reported, therefore causing serious problems for the
correct interpretation of DCFH2 as an indicator of ROS
production [39]. For this reason and in order to evaluate the
convenience of using DCFH2 in the evaluation of ROS production
by melatonin, here it was performed an in vitro study about
possible interactions between both, DFCH2-DA or DCFH2 and
MEL, since those are probably the most widely employed probes
for ROS analysis inside living cells.
Photo-oxidation of MEL has been previously reported in several
occasions [40,41,48]. But while there was no increase in
fluorescence when MEL was exposed to light alone in a free cell
system, a clear increment was found when DCFH2-DA alone was
exposed to light for a long time as previously described by others
[38,39,49,50].
The mechanism of DCFH2 oxidation is not clear yet [47,51,52].
In a previous report, Wrona et al. [53] have shown that a radical
product DCFHN2 occur as an intermediate. DCFHN2 is necessary
since its elimination by reaction with AA or NAC results in no
DCF formation. Accordingly, when DCFH2 and MEL were
incubated together in the absence of light, DCF was not detected,
Figure 7. Diagram of proposal hypothesis about the mechanism of DCFH2, MEL and light reactions.
doi:10.1371/journal.pone.0109257.g007
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thus indicating that light is necessary for fluorescence enhance-
ment.
On the other hand, high concentrations of DCFH2-DA
(100 mM) and MEL (1 mM) are necessary to increase fluorescence
in a cell-free system. Interestingly those experimental conditions
are normally employed by investigations describing pro-oxidant
activity of the indoleamine [27,43–45]. This might explain the
increment observed in DCF after MEL incubation under some
situations without any net increase in ROS production. Our
results prove this fact since antioxidants such as CAT or SOD are
unable to inhibit DCF formation after MEL incubation. Further-
more, our results by using two different cell lines showed that
under light, DCF assay might induce wrong in conclusions. Thus,
MEL is inhibiting DCF formation when the experiment was
performed in complete darkness but after a short exposition to
light DCF fluorescence increase.
An accumulation of DCFH2 in V79 hamster cells after
incubation with 10 mM of DCFH2 has been documented
[46,54]. Considering that we have used high concentrations of
both, DCFH2 (10 mM) and MEL (1 mM) and the uptake of high
concentrations of MEL might be compromised, being intracellular
concentrations of the indole much lower than those applied in the
culture media [55]. Here we studied the ability of MEL to increase
DCF formation when employed at micromolar range concentra-
tion to assure that these observations were feasible to occur in the
intracellular environment. In vitro experiments when MEL
increases DCF fluorescence, high concentration of MEL (1 mM)
in culture medium was used. For this reason, photooxidation of
DCFH2 by MEL is possible as shown here.
Results obtained suggest that the mechanism by which DCF is
produced from DCFH2 and DCFH2-DA is mechanistically
different. As expected, these results confirmed that DCFH2 and
DCFH2-DA are not the most adequate probes to test the ability of
MEL to depurate free radicals in biological systems since
fluorescence is a consequence of a side reaction that do not
involve ROS participation. Also, considering mechanistic differ-
ences between DCFH2 and DCFH2-DA, it seems that DCFH2-
DA could be a better choice since it is necessary a longer light
exposure and a higher concentration to obtain less than 10 times
of fluorescence when employed.
In conclusion, by using DCFH2 staining to measure redox
control by MEL, it could be concluded than MEL might be a pro-
oxidant molecule, while the real situation is very different since it is
still working as an antioxidant compound and scavenging free
radicals as shown in the diagram (Fig. 7). Most of the reactions
shown in the depicted diagram (1–5) have already been
demonstrated in previous reports. Thus, step 1 is due to
physiological pH and step 2 was also previously described
[53,56]. By the effect of radical species or light, DCFH2
2 is
rapidly converted into DCFHN2 (2). AA and NAC acting as direct
scavengers react with DCFHN2 (3) and inhibit DCF2 formation.
DCF2 is generated from DCFHN2 when it reacts with oxygen to
form superoxide (4). Under light, DCF2 absorbs energy and
changes to the excited state DCF2]* (5) and MEL would be able to
react with it to give DCFHN2 and MELN (6). This last reaction has
been described when other molecules [57], such as GSH, are
employed and it might be the reason why MEL is able to augment
DCF fluorescence without increasing ROS production. Further-
more MELN can react with H2O, O2 or O2
N2 to render AFMK (7).
Other possibility is the role of this MELN as catalyst of the reaction
2 obtained MEL as product (RN to R) (8). Thus, the increment in
DCF production by MEL might not be a result of a pro-oxidant
activity, but rather it seems that MEL is still working as an
antioxidant in this context (6).
Altogether results presented here led us to propose that unless
performed under dim red light all time of the performance of the
assay, DCFH2 should not be employed for ROS measuring when
working with melatonin since depending on time, DCFH2 or MEL
concentration, it is possible to detect an increment in DCF2
fluorescence without any increment of ROS more on the contrary,
while melatonin is still working as an antioxidant and a radical
scavenger. Results published in the literature concerning pro-
oxidant activity of melatonin in certain cell types should be re-
evaluated, as this pro-oxidant action does not seem to be the
underlying mechanism by which the indole induces cell death.
Supporting Information
Figure S1 Fluorescence spectrum (lexc = 480 nm,
lem=500–700 nm) of DCFH2-DA (100 mM) plus MEL
(1 mM) under UV light (A), DCFH2 (10 mM) alone (C)
or plus MEL (1 mM) under UV light at short times (B) or
long times (D).
(TIF)
Figure S2 Fluorescence of DCFH2 (10 mM) plus several
concentrations of MEL under light exposure (120 s).
(TIF)
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